Efficacy of Favipiravir in treatment of mild & moderate COVID-19 infection in Nepal: a multi-center, randomized, open-labelled, phase III clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Infectious Diseases"
DOI: 10.1016/j.ijid.2021.12.109
Abstract: Purpose To study tolerability and outcome of oral favipiravir treatment among COVID-19 patients in Nepal. Methods & Materials In this multi-centered randomized, open-labelled phase III clinical trial, we enrolled 18-80 years old, RT-PCR confirmed patients… read more here.
Keywords: randomized open; labelled phase; infection; mild moderate ... See more keywords